Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 106,070,864
- Share change
- +11,151,113
- Total reported value
- $7,694,654,472
- Put/Call ratio
- 94%
- Price per share
- $72.56
- Number of holders
- 283
- Value change
- +$800,559,176
- Number of buys
- 155
- Number of sells
- 102
Report period
Q2 2019
Institutions
283
Top holders
10
ALNY full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
15,945,666
|
$1,490,122,000 | — | 31 Mar 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
14,832,598
|
$1,386,107,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.5%
|
8,659,091
|
$809,194,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
6,428,127
|
$600,707,000 | — | 31 Mar 2019 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.3%
|
5,684,504
|
$531,217,000 | — | 31 Mar 2019 | |
| DODGE & COX |
13F
|
Company |
3.8%
|
4,998,001
|
$467,063,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
3,483,589
|
$325,541,000 | — | 31 Mar 2019 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2.4%
|
3,210,387
|
$300,011,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,748,494
|
$256,847,000 | — | 31 Mar 2019 | |
| BB BIOTECH AG |
13F
|
Company |
1.2%
|
1,631,089
|
$152,425,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
1,220,360
|
$114,043,000 | — | 31 Mar 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.9%
|
1,192,495
|
$111,439,000 | — | 31 Mar 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.87%
|
1,158,138
|
$108,227,996 | — | 31 Mar 2019 | |
| NORGES BANK |
13F
|
Company |
0.86%
|
1,146,869
|
$107,175,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.76%
|
1,017,013
|
$95,040,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
1,006,222
|
$93,966,000 | — | 31 Mar 2019 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.74%
|
987,770
|
$92,307,000 | — | 31 Mar 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.63%
|
835,873
|
$78,112,000 | — | 31 Mar 2019 | |
| 12 West Capital Management LP |
13F
|
Company |
0.55%
|
735,000
|
$68,686,000 | — | 31 Mar 2019 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.53%
|
710,850
|
$66,429,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.49%
|
651,939
|
$60,923,000 | — | 31 Mar 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.47%
|
629,370
|
$58,815,000 | — | 31 Mar 2019 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
622,450
|
$58,168,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
558,305
|
$52,175,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.4%
|
527,151
|
$49,262,000 | — | 31 Mar 2019 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
500,000
|
$46,725,000 | — | 31 Mar 2019 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.37%
|
487,657
|
$45,571,000 | — | 31 Mar 2019 | |
| Slate Path Capital LP |
13F
|
Company |
0.36%
|
480,000
|
$44,856,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.36%
|
474,582
|
$44,349,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
471,024
|
$44,018,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.34%
|
456,281
|
$42,635,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
0.34%
|
450,000
|
$42,053,000 | — | 31 Mar 2019 | |
| Casdin Capital, LLC |
13F
|
Company |
0.33%
|
445,000
|
$41,585,000 | — | 31 Mar 2019 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
417,713
|
$39,035,000 | — | 31 Mar 2019 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
402,500
|
$37,613,000 | — | 31 Mar 2019 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.29%
|
391,221
|
$36,560,000 | — | 31 Mar 2019 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
391,041
|
$36,543,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
390,198
|
$36,463,000 | — | 31 Mar 2019 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.26%
|
351,733
|
$32,869,000 | — | 31 Mar 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
351,013
|
$32,802,000 | — | 31 Mar 2019 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.24%
|
326,000
|
$30,465,000 | — | 31 Mar 2019 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.24%
|
319,923
|
$29,897,000 | — | 31 Mar 2019 | |
| Swiss National Bank |
13F
|
Company |
0.23%
|
302,800
|
$28,297,000 | — | 31 Mar 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.21%
|
284,701
|
$26,606,000 | — | 31 Mar 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.21%
|
282,332
|
$26,384,000 | — | 31 Mar 2019 | |
| Bellevue Group AG |
13F
|
Company |
0.2%
|
267,305
|
$24,980,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
262,166
|
$24,498,000 | — | 31 Mar 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.18%
|
233,500
|
$21,821,000 | — | 31 Mar 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
224,470
|
$20,972,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.17%
|
223,363
|
$20,873,000 | — | 31 Mar 2019 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q2 2019
As of 30 Jun 2019,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,070,864 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, Dodge & Cox, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and RTW INVESTMENTS, LP.
This page lists
283
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
279
Q2 2019 holders
283
Holder diff
4
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.